Patent · US Expired

Compositions and methods for treatment of hyperproliferative diseases

US6624154B1 · kind B1 · utility

5Cited by

5References

39Claims

0Family size

Assignees

Bristol-Myers Squibb Company · US
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
UNIVERSITE LOUIS PASTEUR · FR

Inventors

Gerard BENOIT · Ussel, FR
Hinrich Gronemeyer · Oberkirch, DE
Michel Lanotte · Paris, FR
Marco Gottardis · Princeton, US

Key dates

Filing date	Apr 21, 2000
Grant date	Sep 23, 2003
Priority date	—
Expiry date	Apr 21, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions comprising a retinoid X receptor agonist and an agent capable of activating protein kinase A. The invention also relates to methods of treating hyperproliferative diseases by administering a retinoid X receptor agonist and an agent capable of activating protein kinase A.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.